Rosecrance Inc

Belvidere Clinic

915 Alexandra Drive, Belvidere, IL 61008

Rosecrance Inc Belvidere Clinic is an intensive outpatient and outpatient facility in Belvidere, IL offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment, Medicaid, and private insurance.

Licenses and accreditations

State substance use treatment agencyLicensed by the state's substance use treatment agency.
The Joint CommissionAccredited by The Joint Commission.

Kinds of care

Substance use treatment: Treatment for alcohol and drug use.

Settings

Intensive outpatient treatment: Several hours of treatment a day, several days a week, while living at home.
Outpatient: Regular appointments while living at home.
Outpatient methadone/buprenorphine or naltrexone treatment: Methadone, buprenorphine, or naltrexone for opioid use, with counseling, without staying overnight.
Regular outpatient treatment: Weekly or less frequent appointments while living at home.

Medications for opioid use

Buprenorphine used in Treatment: Buprenorphine is used here.
Naltrexone used in Treatment: Naltrexone is used here.

Accepts clients using MAT but prescribed elsewhere: Accepts clients whose medication for opioid use is prescribed elsewhere.
Buprenorphine maintenance: Buprenorphine continued over time to prevent relapse.
Lofexidine or Clonidine detoxification: Lofexidine or clonidine to ease withdrawal during detox.
Prescribes naltrexone: Prescribes naltrexone.
Relapse prevention with naltrexone: Naltrexone to help prevent relapse.

Payment

Accepted: Cash or self-payment; Federal, state, or local government funding for substance use treatment; Medicaid; Private health insurance; Federal block grants for substance use and mental health services.

Who they serve

Ages served: Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
Sex: Female; Male.
Languages: Sign language services for the deaf and hard of hearing.

More details this facility reports

External Opioid Medications Source: No formal relationship with prescribing entity.
Type of Alcohol Use Disorder Treatment: Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder.
External Source of Medications Used for Alcohol Use Disorder Treatment: In-network prescribing entity; No formal relationship with prescribing entity.
Pharmacotherapies: Acamprosate (Campral®); Buprenorphine (extended-release, injectable); Buprenorphine with naloxone; Buprenorphine without naloxone; Clonidine; Medication for mental disorders; Naltrexone (extended-release, injectable); Naltrexone (oral); Non-nicotine smoking/tobacco cessation.
Treatment Approaches: Cognitive behavioral therapy; Contingency management/motivational incentives; Matrix Model; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy.
Facility Operation (e.g., Private, Public): Private non-profit organization.
Assessment/Pre-treatment: Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for mental disorders; Screening for substance use; Screening for tobacco use.
Testing: Breathalyzer or blood alcohol testing; Drug or alcohol urine screening.
Transitional Services: Aftercare/continuing care; Discharge Planning; Naloxone and overdose education.
Recovery Support Services: Mentoring/peer support.
Education and Counseling Services: Group counseling; Individual counseling; Substance use disorder education.
Facility Smoking Policy: Smoking permitted in designated area.
Facility Vaping Policy: Vaping not permitted.
Ancillary Services: Case management service; Mental health services; Suicide prevention services.

Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.